BSE filing, BSE: 544220. Summary written from the filing by ALFA Finder's alert engine.
Clinitech Laboratory Ltd: key numbers
- Share price
- ₹30.85
- Market cap
- ₹7.04 Cr
- Revenue (annual)
- ₹9.49 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 16.9×Sector 34.1×
- Promoter holding
- 64.62%
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clinitech Laboratory Ltd
All →Clinitech Laboratory Other Announcement
Clinitech Laboratory submitted a certificate confirming the non-applicability of SEBI Regulation 23 regarding Related Party Transactions. This is for the half-year ended September 30, 2026.
Clinitech Laboratory Promoter Reclassification
Clinitech Laboratory Ltd reclassified 12,000 shares held by Mr. Siddhesh Nayak on behalf of Kamaxi Stock Trendz from 'Public' to 'Promoter Group' category.
Clinitech Laboratory Other Announcement
Clinitech Laboratory Limited filed a Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming no rematerialization requests were received.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.
Clinitech Laboratory Board Meeting Date
Clinitech Laboratory Ltd scheduled a Board Meeting for August 17, 2026. The board will discuss director appointments and the 16th AGM.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.